# Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold

> **NCT02916485** · NA · SUSPENDED · sponsor: **Biotronik AG** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Bioresorbable scaffold

## Key facts

- **NCT ID:** NCT02916485
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-09
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** Awaiting National Pharmaceutical Pricing Authority (NPPA) review of ceiling prices for innovative products in India.
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916485, "Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02916485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*